← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:1226 | 1226 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6084 | 71286-6084-1 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1226 | 1226 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-932 | 69374-932-03 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1226 | 1226 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1226 | 1226 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-025 | 71506-025-58 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1226 | 1226 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-932 | 69374-932-03 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1226 | 1226 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6065 | 71286-6065-1 | Neostigmine Methylsulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1226 | 1226 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-041 | 79926-041-01 | Prednisolone Acetate | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1226 | 1226 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-042 | 70092-042-05 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1226 | 1226 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1226 | 1226 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1226 | 1226 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Acetate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1226 | 1226 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-156 | 63037-156-25 | Rocuronium Bromide | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1226 | 1226 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-4002 | 73013-4002-2 | Ropivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1226 | 1226 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-113 | 69194-113-01 | Sodium 3-Hydroxybutyrate | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1226 | 1226 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-034 | 71506-034-05 | Succinylcholine Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1227 | 1227 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-502 | 69761-502-01 | Testosterone / Stearic Acid | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1227 | 1227 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1227 | 1227 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1227 | 1227 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8096 | 72196-8096-1 | Norepinephrine Bitartrate | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1227 | 1227 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-027 | 71506-027-58 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1227 | 1227 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-902 | 69374-902-05 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1227 | 1227 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6065 | 72196-6065-1 | Neostigmine Methylsulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1227 | 1227 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-040 | 79926-040-01 | Prednisolone Acetate | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1227 | 1227 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6058 | 72196-6058-1 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1227 | 1227 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1227 | 1227 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1227 | 1227 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9055 | 83826-9055-5 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1227 | 1227 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-159 | 73177-159-03 | Rocuronium Bromide | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1227 | 1227 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1227 | 1227 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sodium Bicarbonate | 2025-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2026-1:1227 | 1227 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2026-1 | source_no_ndc | 1 | 2026-10-21 | |||
compounder:1228 | 1228 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0630 | 70168-0630-1 | Testosterone Cypionate/DHEA 200/10mg/mL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1228 | 1228 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1228 | 1228 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1228 | 1228 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8097 | 72196-8097-1 | Norepinephrine Bitartrate | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1228 | 1228 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-032 | 71506-032-58 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1228 | 1228 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1228 | 1228 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1228 | 1228 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Acetate | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1228 | 1228 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7025 | 72196-7025-1 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1228 | 1228 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-008 | 71506-008-58 | Phenylephrine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1228 | 1228 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-301 | 73463-301-04 | Phenylephrine Hydrochloride | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1228 | 1228 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-002 | 81375-002-05 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1228 | 1228 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-159 | 73177-159-02 | Rocuronium Bromide | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1228 | 1228 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-109 | 73177-109-26 | Ropivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1228 | 1228 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-984 | 69374-984-10 | Sodium Bicarbonate; Lidocaine Hydrochloride; Potassium Chloride | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1228 | 1228 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2026-1 | source_no_ndc | 1 | 2026-10-21 | |||
compounder:1229 | 1229 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0007 | 81483-0007-2 | Ketamine | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1229 | 1229 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1229 | 1229 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1229 | 1229 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6057 | 71285-6057-1 | Norepinephrine Bitartrate | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1229 | 1229 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-471 | 76154-471-15 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1229 | 1229 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1229 | 1229 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1229 | 1229 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Acetate; Moxifloxacin Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1229 | 1229 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-807 | 70004-807-40 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1229 | 1229 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-811 | 70004-811-40 | Phenylephrine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1229 | 1229 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-008 | 71506-008-58 | Phenylephrine Hydrochloride | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1229 | 1229 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-200 | 81375-200-05 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1229 | 1229 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1229 | 1229 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-109 | 73177-109-13 | Ropivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1229 | 1229 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-100 | 82396-100-10 | Sodium Chloride | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1229 | 1229 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-116 | 73177-116-02 | Succinylcholine Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1230 | 1230 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5616 | 26436-5616-3 | TESTOSTERONE | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1230 | 1230 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3325 | 62295-3325-5 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1230 | 1230 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1230 | 1230 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6056 | 71285-6056-1 | Norepinephrine Bitartrate | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1230 | 1230 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-472 | 76154-472-15 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1230 | 1230 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-002 | 72055-002-01 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1230 | 1230 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-2 | Neostigmine Methylsulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1230 | 1230 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-300 | 81375-300-08 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1230 | 1230 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-150 | 71449-150-82 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1230 | 1230 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-811 | 70004-811-12 | Phenylephrine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1230 | 1230 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-024 | 71506-024-58 | Phenylephrine Hydrochloride | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1230 | 1230 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9033 | 83826-9033-5 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1230 | 1230 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1230 | 1230 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-109 | 73177-109-20 | Ropivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1230 | 1230 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sodium Chloride | 2025-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2026-1:1230 | 1230 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-116 | 73177-116-03 | Succinylcholine Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1231 | 1231 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2002 | 71266-2002-9 | Rocuronium Bromide | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1231 | 1231 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1231 | 1231 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1231 | 1231 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1231 | 1231 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-473 | 76154-473-15 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1231 | 1231 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1549 | 5446-1549-05 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1231 | 1231 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-1 | Neostigmine Methylsulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1231 | 1231 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-300 | 81375-300-05 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1231 | 1231 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-001 | 71449-001-11 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1231 | 1231 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-805 | 70004-805-40 | Phenylephrine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1231 | 1231 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-026 | 71506-026-51 | Phenylephrine Hydrochloride | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1231 | 1231 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-300 | 81375-300-05 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1231 | 1231 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1231 | 1231 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-109 | 73177-109-14 | Ropivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1231 | 1231 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0204 | 71285-0204-1 | Sodium Chloride; Magnesium Sulfate Heptahydrate; Potassium Chloride; Sodium Bicarbonate; Calcium Chloride | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1231 | 1231 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2026-1 | source_no_ndc | 1 | 2026-10-21 | |||
compounder:1232 | 1232 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-01 | Morphine Sulfate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1232 | 1232 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1232 | 1232 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1232 | 1232 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1232 | 1232 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-474 | 76154-474-15 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1232 | 1232 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1232 | 1232 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-15 | Neostigmine Methylsulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1232 | 1232 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prilocaine Hydrochloride; Cyclobenzaprine Hydrochloride; Baclofen; Lidocaine Hydrochloride; Ketoprofen | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1232 | 1232 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-123 | 73702-123-10 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1232 | 1232 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1232 | 1232 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1232 | 1232 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-300 | 81375-300-08 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1232 | 1232 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1232 | 1232 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-588 | 70092-588-38 | Ropivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1232 | 1232 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0203 | 71285-0203-1 | Sodium Chloride; Magnesium Sulfate Heptahydrate; Potassium Chloride; Sodium Bicarbonate; Calcium Chloride | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1232 | 1232 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2026-1 | source_no_ndc | 1 | 2026-10-21 | |||
compounder:1233 | 1233 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-601 | 81375-601-01 | Semaglutide | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1233 | 1233 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1233 | 1233 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1233 | 1233 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1233 | 1233 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1233 | 1233 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1372 | 61141-1372-5 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1233 | 1233 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-53 | Neostigmine Methylsulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1233 | 1233 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prilocaine Hydrochloride; Lidocaine | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1233 | 1233 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-004 | 68985-004-94 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1233 | 1233 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-7084 | 71139-7084-1 | Phenylephrine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1233 | 1233 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-108 | 73177-108-03 | Phenylephrine Hydrochloride | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1233 | 1233 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6028 | 26436-6028-3 | Procaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1233 | 1233 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1233 | 1233 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-333 | 70092-333-75 | Ropivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1233 | 1233 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0212 | 71285-0212-1 | Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Lidocaine Hydrochloride; Sodium Bicarbonate | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1233 | 1233 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2026-1 | source_no_ndc | 1 | 2026-10-21 | |||
compounder:1234 | 1234 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-640 | 71170-640-01 | Semaglutide 1mg and Cyanocobalamin 0.5mg | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1234 | 1234 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-781 | 76154-781-73 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1234 | 1234 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1234 | 1234 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8095 | 71285-8095-1 | Norepinephrine Bitartrate | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1234 | 1234 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-475 | 76154-475-15 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1234 | 1234 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1234 | 1234 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1234 | 1234 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-6142 | 73271-6142-1 | Prilocaine; Lidocaine; Tetracaine; Phenylephrine | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1234 | 1234 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-049 | 68985-049-91 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1234 | 1234 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1234 | 1234 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1418 | 61141-1418-1 | Phenylephrine Hydrochloride | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1234 | 1234 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 67157-005 | 67157-005-30 | Procaine; Sodium Metabisulfite | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1234 | 1234 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1234 | 1234 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-335 | 70092-335-76 | Ropivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1234 | 1234 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sodium Tetradecyl Sulfate | 2025-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2026-1:1234 | 1234 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2026-1 | source_no_ndc | 1 | 2026-10-21 | |||
compounder:1235 | 1235 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-212 | 69761-212-01 | Testosterone / Anastrozole | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1235 | 1235 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-782 | 76154-782-75 | Glycopyrrolate | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1235 | 1235 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0329 | 60652-0329-1 | Neostigmine Methylsulfate | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1235 | 1235 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8096 | 71285-8096-1 | Norepinephrine Bitartrate | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1235 | 1235 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-476 | 76154-476-15 | Norepinephrine Bitartrate | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1235 | 1235 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1235 | 1235 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1235 | 1235 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-7142 | 73271-7142-1 | Prilocaine; Lidocaine; Tetracaine; Phenylephrine | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1235 | 1235 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-1:1235 | 1235 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1235 | 1235 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-010 | 71506-010-58 | Phenylephrine Hydrochloride | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1235 | 1235 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-026 | 70713-026-01 | Progesterone | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1235 | 1235 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1235 | 1235 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-657 | 70092-657-76 | Ropivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1235 | 1235 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1591 | 72934-1591-2 | Spironolactone; Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1235 | 1235 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2001 | 71266-2001-1 | Succinylcholine Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1236 | 1236 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-140 | 69194-140-01 | 140 CATARACTIVE MDB DROPS 0.5%-0.1%-0.035% 5mL | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1236 | 1236 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2304 | 72627-2304-1 | Growth Hormone Releasing Hexapeptide; Sermorelin Acetate; Pralmorelin | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1236 | 1236 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1236 | 1236 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1236 | 1236 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-500 | 71170-500-25 | Norepinephrine; Sodium Chloride; Sodium Metabisulfite | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1236 | 1236 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0894 | 5446-0894-01 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1236 | 1236 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1236 | 1236 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-8142 | 73271-8142-1 | Prilocaine; Lidocaine; Tetracaine; Phenylephrine | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1236 | 1236 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-1:1236 | 1236 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1236 | 1236 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-040 | 71506-040-10 | Phenylephrine Hydrochloride | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1236 | 1236 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-1124 | 26436-1124-1 | Progesterone | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1236 | 1236 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-4001 | 73013-4001-1 | Ropivacaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1236 | 1236 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9130 | 71266-9130-1 | Ropivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1236 | 1236 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2590 | 72934-2590-2 | Spironolactone; Dapsone; Niacinamide | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1236 | 1236 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2001 | 71266-2001-3 | Succinylcholine Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1237 | 1237 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9015 | 71266-9015-5 | Glycopyrrolate | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1237 | 1237 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2306 | 72627-2306-1 | Growth Hormone Releasing Hexapeptide; Sermorelin Acetate; Pralmorelin | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1237 | 1237 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1237 | 1237 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6157 | 71285-6157-1 | Norepinephrine Bitartrate | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1237 | 1237 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-510 | 71170-510-25 | Norepinephrine; Sodium Chloride; Sodium Metabisulfite | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1237 | 1237 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1237 | 1237 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3151 | 72627-3151-1 | Niacinamide; Tretinoin | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1237 | 1237 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-9142 | 73271-9142-1 | Prilocaine; Lidocaine; Tetracaine; Phenylephrine | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1237 | 1237 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-301 | 73463-301-04 | Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1237 | 1237 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-045 | 70092-045-05 | Phenylephrine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1237 | 1237 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-112 | 73177-112-03 | Phenylephrine Hydrochloride | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1237 | 1237 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5248 | 26436-5248-1 | Progesterone | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1237 | 1237 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-4001 | 73013-4001-2 | Ropivacaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1237 | 1237 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-070 | 71449-070-25 | Ropivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1237 | 1237 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine | 2025-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2026-1:1237 | 1237 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2001 | 71266-2001-9 | Succinylcholine Chloride | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1238 | 1238 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7558 | 72934-7558-6 | Dionaris | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1238 | 1238 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2305 | 72627-2305-1 | Growth Hormone Releasing Hexapeptide; Sermorelin Acetate; Pralmorelin | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1238 | 1238 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nicardipine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1238 | 1238 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8097 | 71285-8097-1 | Norepinephrine Bitartrate | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1238 | 1238 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-012 | 71506-012-55 | Ondansetron Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1238 | 1238 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-15 | Neostigmine Methylsulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1238 | 1238 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4834 | 61141-4834-1 | Nitroglycerin | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1238 | 1238 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Procaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1238 | 1238 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-21 |